Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GABAA receptor agent 7 (compoud 5c) has anticonvulsant activity both in vitro and in vivo with low neurotoxicity which can be used in epilepsy research. GABAA receptor agent 7 is a potent positive modulator of GABAA receptor [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | GABAA receptor agent 7 (compoud 5c) has anticonvulsant activity both in vitro and in vivo with low neurotoxicity which can be used in epilepsy research. GABAA receptor agent 7 is a potent positive modulator of GABAA receptor [1]. |
In vitro | GABAA receptor agent 7 (compound 5c) exhibits anticonvulsant properties, demonstrating an inhibitory concentration (IC50) of 0.452 μM in the 4-AP induced hyper-excitability model [1]. Additionally, it enhances GABA-induced activation of the GABAA1 receptor dose-dependently within a concentration range of 0.01-100 μM over a period of 0-140 seconds, with an effective concentration (EC50) of 3.08 μM [1]. |
In vivo | GABAA receptor agent 7 demonstrates anticonvulsant properties in mice, achieving an effective dose 50 (ED50) of 31.81 mg/kg and a toxic dose 50 (TD50) of 547.89 mg/kg [1]. This compound specifically mitigates seizures induced by pentylenetetrazol (PTZ) without affecting those caused by maximal electroshock (MES) in mice [1]. |
Molecular Weight | 336.77 |
Formula | C18H13ClN4O |
CAS No. | 2376841-18-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GABAA receptor agent 7 2376841-18-6 inhibitor inhibit